Ambrx Biopharma Inc - ADR

Great News! Now you can buy fractional shares of Ambrx Biopharma Inc - ADR

What is Fractional Shares?

Fractional shares are pieces of one full share of a company or exchange-traded fund (ETF).

In INDmoney, you can buy Ambrx Biopharma Inc - ADR stock in any dollar amount, or any other stock you want.

$10

$50

$100

AMAM

Ambrx Biopharma Inc - ADR (AMAM)

Q: What is Ambrx Biopharma Inc - ADR (AMAM) share price today?

Ambrx Biopharma Inc - ADR (AMAM) share price today is $10.72

Q: Can Indians buy Ambrx Biopharma Inc - ADR (AMAM) shares?

Yes, Indians can buy Ambrx Biopharma Inc - ADR (AMAM) shares. As per RBI rule, an Indian citizen can invest 250,000 dollars a year in foreign markets.

Q: How can I buy Ambrx Biopharma Inc - ADR (AMAM) shares from India?

Three ways to invest in Ambrx Biopharma Inc - ADR (AMAM) stocks from India are 1.Investment through apps: INDmoney is one of the leading apps that help you invest in Ambrx Biopharma Inc - ADR (AMAM) stocks from India 2.Investment through Indian brokers tied up with a foreign broker 3.Investment by opening an account with a Foreign broker

Q: Can Fractional shares of Ambrx Biopharma Inc - ADR (AMAM) be purchased?

You can buy just a fraction of Ambrx Biopharma Inc - ADR (AMAM) shares.

Q: What are the documents required to start investing in Ambrx Biopharma Inc - ADR (AMAM) stocks?

You will need a proof of Identification (PAN, Aadhaar etc) and proof of address (Aadhaar, Voter ID etc) to invest in Ambrx Biopharma Inc - ADR (AMAM) stocks . The entire process is paperless and can be completed seamlessly.

$10.721.32%▲

Key Stats

Open	$10.72
Today Low/High	$10.72 / $10.72
52 Week Low/High	$10 / $22.87
Market Cap	$390.26M

Company Details

Ambrx is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. These include next generation antibody drug conjugates (ADCs), bispecifics, targeted immuno-oncology therapies, novel cytokines to modulate the immune system, and long-acting therapeutic peptides for metabolic and cardiovascular disease. Ambrx is advancing a robust portfolio of clinical and preclinical programs designed to optimize efficacy, safety and ease of use, in multiple therapeutic areas, including its lead product candidate ARX788. In addition, the company has clinical collaborations with Bristol Myers Squibb, Astellas, BeiGene, Sino Biopharma, Elanco and NovoCodex, for drug candidates generated using Ambrx technology.

Discover more

Sensei Biotherapeutics Inc

$7.82

-5.44%▲

Surface Oncology Inc

$5.7

+0.71%▲

UpHealth Inc

$2.7

Impel NeuroPharma Inc.

$9.6

+3%▲

Vaccitech plc

$12.4

-6.06%▲

Gemini Therapeutics Inc

$2.92

-5.81%▲

Digimarc Corporation

$39.68

-6.99%▲

Explore all

Frequently Asked Questions

What is Ambrx Biopharma Inc - ADR (AMAM) share price today?

Can Indians buy Ambrx Biopharma Inc - ADR (AMAM) shares?

How can I buy Ambrx Biopharma Inc - ADR (AMAM) shares from India?

Can Fractional shares of Ambrx Biopharma Inc - ADR (AMAM) be purchased?

What are the documents required to start investing in Ambrx Biopharma Inc - ADR (AMAM) stocks?

Markets:

Stocks:

Best Mutual Funds:

Mutual Funds:

US Stocks:

US Stocks Guide:

Bonds:

Tools:

Explore AMCs:

INDmoney, INDwealth, IND.app, IND.money, INDsave.com are brand and product of Finzoom Investment Advisors (P) Limited.

Finzoomers Services Private Limited - [Registered address: 624-625, 6th Floor, Suncity Success Tower, Golf Course Extension Road, Sector - 65 Gurugram – HR- 122005] [IRDAI Corporate Agent (Composite) Registration No- CA0744 Validity till - 02/03/2024] [Principal Officer- Mr. Ankur Goyal, Principal Officer email id- po@finzoomers.in] [CIN: U74990HR2020PTC086201] [GST No: 06AAECF0692E1ZV] [Email id: insurancesupport@indmoney.com]

Finzoom Investment Advisors Private Limited makes no warranties or representations, express or implied, on products and services offered through the platform. It accepts no liability for any damages or losses, however, caused in connection with the use of, or on the reliance of its advisory or related services.

Past performance is not indicative of future returns. Please consider your specific investment requirements, risk tolerance, goal, time frame, risk and reward balance and the cost associated with the investment before choosing a fund, or designing a portfolio that suits your needs. Performance and returns of any investment portfolio can neither be predicted nor guaranteed.

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.

Marketing and distribution of various financial products such as loans, deposits and Insurance are powered by Finzoomers Services Private Limited.

[SEBI RIA Registration No: INA100012190] [Type of Registration: Non-Individual] [Validity of registration: December 17, 2018-Perpetual] [Address: 616, 6th Floor, Suncity Success Tower, Golf Course Extension Road, Sector – 65, Gurugram, Haryana- 122005] [Corresponding SEBI local office address: Securities and Exchange Board of India, Local Office, First Floor, SCO 127-128, Sector 17C, Chandigarh-160017][Principal Officer details: Mr. Gaurav Sharma, Email id: principalofficer@indmoney.com]

[ARN - 151913] [Platform Partner : BSE (Member code-24801)] [CIN - U67190HR2018PTC073294] [GST No : 06AADCF3538Q1Z8]

US stocks watchlist

Mutual Funds watchlist